<code id='C5814026C2'></code><style id='C5814026C2'></style>
    • <acronym id='C5814026C2'></acronym>
      <center id='C5814026C2'><center id='C5814026C2'><tfoot id='C5814026C2'></tfoot></center><abbr id='C5814026C2'><dir id='C5814026C2'><tfoot id='C5814026C2'></tfoot><noframes id='C5814026C2'>

    • <optgroup id='C5814026C2'><strike id='C5814026C2'><sup id='C5814026C2'></sup></strike><code id='C5814026C2'></code></optgroup>
        1. <b id='C5814026C2'><label id='C5814026C2'><select id='C5814026C2'><dt id='C5814026C2'><span id='C5814026C2'></span></dt></select></label></b><u id='C5814026C2'></u>
          <i id='C5814026C2'><strike id='C5814026C2'><tt id='C5814026C2'><pre id='C5814026C2'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:6
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          The EU Joint Clinical Assessment needs to live up to its promise
          The EU Joint Clinical Assessment needs to live up to its promise

          RonaldWittek,PoolPhotoviaAPToday,thecriteriausedtoassesstheclinicalvalueofnewpharmaceuticalsandmedic

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Beam Therapeutics to lay off 20% of its staff, re

          BeamTherapeuticsco-founderDavidLiuCourtesyStephanieMitchell/HarvardBeamTherapeuticssaidThursdaymorni